Ergoteles’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-23,000
Closed -$251K 1667
2022
Q4
$251K Sell
23,000
-6,530
-22% -$71.2K 0.01% 979
2022
Q3
$249K Buy
+29,530
New +$249K 0.01% 1075
2021
Q1
Sell
-11,700
Closed -$236K 1007
2020
Q4
$236K Buy
+11,700
New +$236K 0.01% 573